期刊文献+

血液透析患者的血压变异性观察 被引量:1

下载PDF
导出
摘要 目的:观察血液透析患者的血压变异性情况。方法:选择在陕西省人民医院和陕西省第四人民医院进行诊治的血液透析患者52例,均进行透析治疗,观察预后情况与血压变异情况。结果:所有患者完成透析,发生透析高血压10例,发生率为19.2%。发生不良反应6例,发生率为11.5%。透析后患者的SBP、DBP与MAP值都呈现明显增加的趋势(P<0.05),其中透析2 h患者的SBP、DBP与MAP值都在最高峰值,对比差异有统计学意义(P<0.05)。结论:血液透析患者多伴随有高血压与血压变异现象,在透析后血压明显增加,要积极进行干预。
出处 《实用中西医结合临床》 2014年第10期43-44,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献8

二级参考文献69

  • 1彭金霞,董捷,徐莉,薛津津,左力,王梅.血容量监测运用于血液透析患者干体重评价中的护理[J].护士进修杂志,2005,20(11):1011-1013. 被引量:4
  • 2梁莉,黄云剑,袁发焕,杨惠标.应用血容量监测调整血液透析患者干体重的护理研究[J].解放军护理杂志,2005,22(10):7-8. 被引量:5
  • 3蒋礼,张玲,殷跃辉,佘强,黄晶,潘重辉.原发性高血压病对早期肾功能的影响[J].临床医学,2007,27(2):1-3. 被引量:9
  • 4徐太静(综述),严海东(审校).血容量监测方法及其在血液透析中的应用研究进展[J].国际泌尿系统杂志,2007,27(4):563-566. 被引量:3
  • 5Gwathmey TM,Pendergrass KD,Reid SD,et al.Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin Ⅱ within the cell nucleus.Hypertension,2010,55:166-171.
  • 6Griendling KK,Ushio-Fukai M.Reactive oxygen species as mediators of angiotensin Ⅱ signaling.Regul Pept,2000,91:21-27.
  • 7Moens AL,Kass DA.Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.J Cardiovasc Pharmacol,2007,50:238-246.
  • 8Akasaki T,Ohya Y,Kuroda J,et al.Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension:involvement of the renin-angiotensin system.Hypertens Res,2006,29:813-820.
  • 9Thomas SR,Witting PK,Drummond GR.Redox control of endothelial function and dysfunction:molecular mechanisms and therapeutic opportunities.Antioxid Redox Signal,2008,10:1713-1765.
  • 10Carlstrm M,Lai EY,Ma Z,et al.Role of NOX2 in the regulation of afferent arteriole responsiveness.Am J Physiol Regul Integr Comp Physiol,2009,296:R72-R79.

共引文献43

同被引文献20

  • 1Kouw PM, Olthof CG, Ter Wee PM, et al. Assessment of post-dialysis dry weight:An application of the conduc- tivity measurement method [J]. Kidney Int, 1992, 41(2): 440-444.
  • 2Katzarski K, Charra B, Laurent G, et al. Multifrequency bioimpedance in assessment of weight in haemodialysis [J].Nephrol Dial Trans, 1996, 11(Suppl 2):20-23.
  • 3Agarwal R, Satyan S, Alborzi P, et al. Home blood pressure measurements for managing hypertension in hemodialysis patients[J].Am J Nephrol, 2009, 30(2):126-134.
  • 4Inrig JK, Oddone EZ, Hasselblad V, et al. Assoeiation of intradialytic blood pressure changes with hospital- ization and mortality rates in prevalent ESRD patients [J].Kidney Int, 2007, 71(5):454-461.
  • 5Flythe d E, Inrig J K, Shafi T, et al. Assoeiation of intradialytic blood pressure variability with in- creased all-cause and cardiovascular mortality in pa- tients treated with long-term hemodialysis[J].AM J Kid- ney Dis, 2013, 61, (6):966-974.
  • 6Kamyar KZ, Ryan D, Kilpatrick, et ai. Reverse Epidemi ology of Hypertension and Cardiovascular Death in the Hemodialysis Population[J].Hypertension, 2005, 45(4): 811-817.
  • 7Andrew Davenport. Intradialytic complications during he-- modialysis[J].Hemodialysis Int, 2006, I0(2):162-167.
  • 8Park J, Rhee CM, Sim JJ, et al.A comparative effective-- ness research study of the change in blood pressure during hemodialysis treatment and survival[J].Kidney Int, 2013, 84(4):795-802.
  • 9Dinesh K, Kunaparaju S, Cape K, et al.A model of sys- tolic Blood Pressure During the Course of Diadysis and Clinical Factors Associated With Various Blood Pres- sure Behaviours[J].Am J Kidney Dis, 2011, 58(5):794- 803.
  • 10Chazot C. Jean G. Intradialytic Hypertension: it is time to aet[J].Nephron Clin Praet, 2010, i15(3):c182-188.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部